2021
DOI: 10.1016/j.clinre.2020.04.006
|View full text |Cite
|
Sign up to set email alerts
|

LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 27 publications
0
6
0
Order By: Relevance
“…In liver fibrosis, lumican regulates the assembly of collagen fibers and activates TGF-β and SMA. Moreover, upregulated lumican expression is observed in patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, substantiating its role in liver fibrosis ( Charlton et al ., 2009 ; Barbariga et al ., 2019 ; Mohammadzadeh et al ., 2019 ; Chang et al ., 2021 ). In our study, Il1r2 and Irak3 emerged as the most strongly affected genes following PHMG-p treatment.…”
Section: Discussionmentioning
confidence: 99%
“…In liver fibrosis, lumican regulates the assembly of collagen fibers and activates TGF-β and SMA. Moreover, upregulated lumican expression is observed in patients with non-alcoholic fatty liver disease and non-alcoholic steatohepatitis, substantiating its role in liver fibrosis ( Charlton et al ., 2009 ; Barbariga et al ., 2019 ; Mohammadzadeh et al ., 2019 ; Chang et al ., 2021 ). In our study, Il1r2 and Irak3 emerged as the most strongly affected genes following PHMG-p treatment.…”
Section: Discussionmentioning
confidence: 99%
“…LUM and DCN exert influence on ECM composition, thereby modulating the fibrotic progression. It was found that elevated LUM levels observed in the hepatic tissue and serum of individuals afflicted with advanced fibrosis suggest the potential utility of LUM as a diagnostic biomarker for assessing the severity of NAFLD liver fibrosis [ 38 ]. DCN operates by sequestering transforming growth factor β (TGFβ), a pivotal profibrogenic cytokine, thereby impeding its activity.…”
Section: Discussionmentioning
confidence: 99%
“…The levels of type III collagen formation and degradation were significantly increased in ALD patients compared to healthy individuals ( 46 ). In addition, LUM has been identified as a biomarker for advanced fibrosis in non-alcoholic fatty liver disease ( 47 ). THBS2 is a novel biomarker for predicting the prognosis of metastatic pancreatic ductal adenocarcinoma ( 48 ).…”
Section: Discussionmentioning
confidence: 99%